HOME >> BIOLOGY >> NEWS
Study identifies new tumor suppressor

A protein called HLJ1 may work as a novel tumor suppressor in non-small-cell lung carcinoma, according to a study in the June 21 issue of the Journal of the National Cancer Institute.

Jeremy J.W. Chen, Ph.D., of National Chung-Hsing University, Pan-Chyr Yang, M.D., Ph.D., of National Taiwan University in Taiwan, and colleagues increased or blocked the expression of HLJ1 in lung carcinoma cells in the lab and examined the gene's expression in tumor and surrounding tissue cells of 71 patients with non-small-cell lung cancer. HLJ1 is a protein involved in a cell's defense mechanism against outside stress.

The authors observed that HLJ1 stopped proliferation of lung cancer cells, slowed the cell division cycle's progression, and inhibited the cells' ability to move and invade other tissues. In addition, HLJ1 expression was lower in tumor tissue than normal tissue in 55 of the 71 patients studied, and patients with high HLJ1 expressing tumors had reduced cancer recurrence and lived longer than those with low expressing tumors. The authors conclude that HLJ1 expression is a novel tumor suppressor in non-small-cell lung cancer. The authors write, "These findings may identify a subgroup of non-small-cell lung cancer patients who may benefit from adjuvant therapy and facilitate the design of individualized therapies for lung cancer."

In an accompanying editorial, Adriana Albini, Ph.D., and Ulrich Pfeffer, Ph.D., of the National Cancer Research Institute in Genova, Italy, write, "The article by [Chen and colleagues] will further stimulate scrutiny of the [proteins in the same family as HLJ1] and put cancer invasion, angiogenesis, and metastasis back on the list of functions inhibited by oncosuppressor genes in lung and perhaps other organs."


'"/>

Contact: Ariel Whitworth
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
20-Jun-2006


Page: 1

Related biology news :

1. Study begins to reveal clues to the cause and progression of sepsis
2. Study finds gender differences in renal and other genes contributing to blood pressure
3. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
4. Study: Sticking to the sand might not be such good, clean fun for beachgoers
5. Study points to new way to predict death risk from torn aorta
6. Study identifies new gene therapy tools for inherited blindness
7. Study finds contaminated water reaching Floridas offshore keys
8. Study sheds light on why humans walk on two legs
9. Study explains how pathogens evolve to escape detection
10. Study finds hereditary link to premenstrual depression
11. Study identifies energy efficiency as reason for evolution of upright walking

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/5/2018)... ... October 04, 2018 , ... High dose of biotin may cause ... such as cardiac troponin has serious clinical complications. There is an increasing trend of ... still unknown. , High dose of biotin supplement use may continue to increase ...
(Date:10/3/2018)... ... October 03, 2018 , ... ... commercialization of first-in-class stromal cell immunotherapies, announced that ORBCEL-M™, a second generation ... diabetes and progressive diabetic kidney disease in a four-site, pan-European Phase I/II ...
(Date:10/2/2018)... , ... October 02, 2018 , ... Through this webinar, ... 1536-well FLIPR screening. They will also learn the role of calcium kinetics in cardiac ... the chief operations officer at PPSC Biography; and Tsang Wai Lam, an assay development ...
Breaking Biology News(10 mins):
(Date:9/27/2018)... ... September 27, 2018 , ... This past weekend ... SureAdhere Mobile Technology, Inc. announced they will formally merge companies and integrate their ... tuberculosis (TB) and other diseases. These two social enterprise corporations, both of which ...
(Date:9/22/2018)... ... September 20, 2018 , ... Catalent Pharma Solutions, the ... and consumer health products, today announced that it will be co-hosting a workshop ... Pharmaceutical Development,”. The one-day event is to be held at the Hilton Boston ...
(Date:9/13/2018)... ... September 13, 2018 , ... Asymmetrex’s director, James L. Sherley, ... gotten in medicine, if we didn’t have the means to measure the number of ... His answer, “Nowhere! And that is what’s holding up progress in stem cell medicine.” ...
(Date:9/12/2018)... Va. (PRWEB) , ... September 12, 2018 , ... ... Lauren Bronich-Hall, a quality management professional and former Senior Director of Regulatory Affairs ... Consultant. , As Senior Director of Regulatory Affairs and Quality Systems at ...
Breaking Biology Technology:
Cached News: